However, differences in the degree of BMD change caused by anastrozole between elderly breast cancer patients and their younger counterparts could also be due to some extend to a different sensitivity of hormone receptors to circulating estradiol, developed by aging. This evidence concerns the gene NR4A1 and breast carcinoma.